Telum Therapeutics has become a member of the Spanish Bioindustry Association (Asebio), which strategically promotes the Spanish biotechnology sector and includes more than 300 companies, start-ups and organisations.
The main working areas of Asebio, chaired by Ana Polanco (Merck) and directed by Ion Arocena, are healthcare (innovation, advanced therapies, personalised medicine, drug discovery and antibiotic resistance), sustainability, the ecosystem, social impact and internationalisation.
Joining Asebio is an excellent opportunity to connect Telum Therapeutics, as a company that develops innovative antimicrobial drugs to treat infectious diseases caused by multidrug-resistant bacteria, with the ecosystem.
Read Asebio’s interview with Telum Therapeutics CEO and Co-Founder, Dr Roberto Díez-Martínez.
